Inspire Medical Systems, Inc.
INSPHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeInspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the. The company carries a $1.46B market cap, placing it firmly in the small-cap category. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA.
Market Cap
$1.46B
Beta
0.71
P/E (TTM)
11.71
P/E (Fwd)
40.07
EPS (TTM)
$4.32
EPS (Fwd)
$1.26
ROE
18.4%
ROA
3.9%
Cash
$283.8M
Total Debt
$29.6M
Free CF
$85.6M
52W Change
-60.1%
Annual Financials
Cash vs Debt
The balance sheet looks solid with $283.8M in cash comfortably exceeding the $29.6M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Free cash flow comes in at $85.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 18.4%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.9% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $407.9M (2022) to $912.0M (2025), reflecting a 124% increase over the period.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing INSP.